A liquid biopsy-based proteomic assay to identify circulating tumor cell (CTC) –derived druggable targets in cancer patients.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Spectroscopy
Field: Chemistry
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4407701640
